In some patients, metformin has been tried—already used for patients with type 2 diabetes and for the treatment of obesity in children and adults—to improve circadian rhythms and restore memory deficits precisely because these problems can be explained in patients with fragile X by the dysregulation of insulin signaling. This evidence concerns the gene INS and obesity disorder.